• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用人工智能预测前列腺癌的生化复发

Predicting biochemical recurrence of prostate cancer with artificial intelligence.

作者信息

Pinckaers Hans, van Ipenburg Jolique, Melamed Jonathan, De Marzo Angelo, Platz Elizabeth A, van Ginneken Bram, van der Laak Jeroen, Litjens Geert

机构信息

Department of Pathology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Department of Pathology, New York University Langone Medical Center, New York, NY USA.

出版信息

Commun Med (Lond). 2022 Jun 8;2:64. doi: 10.1038/s43856-022-00126-3. eCollection 2022.

DOI:10.1038/s43856-022-00126-3
PMID:35693032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9177591/
Abstract

BACKGROUND

The first sign of metastatic prostate cancer after radical prostatectomy is rising PSA levels in the blood, termed biochemical recurrence. The prediction of recurrence relies mainly on the morphological assessment of prostate cancer using the Gleason grading system. However, in this system, within-grade morphological patterns and subtle histopathological features are currently omitted, leaving a significant amount of prognostic potential unexplored.

METHODS

To discover additional prognostic information using artificial intelligence, we trained a deep learning system to predict biochemical recurrence from tissue in H&E-stained microarray cores directly. We developed a morphological biomarker using convolutional neural networks leveraging a nested case-control study of 685 patients and validated on an independent cohort of 204 patients. We use concept-based explainability methods to interpret the learned tissue patterns.

RESULTS

The biomarker provides a strong correlation with biochemical recurrence in two sets ( = 182 and  = 204) from separate institutions. Concept-based explanations provided tissue patterns interpretable by pathologists.

CONCLUSIONS

These results show that the model finds predictive power in the tissue beyond the morphological ISUP grading.

摘要

背景

根治性前列腺切除术后转移性前列腺癌的首个迹象是血液中前列腺特异性抗原(PSA)水平升高,即生化复发。复发的预测主要依赖于使用 Gleason 分级系统对前列腺癌进行形态学评估。然而,在该系统中,目前忽略了分级内的形态学模式和细微的组织病理学特征,大量的预后潜力尚未得到探索。

方法

为了利用人工智能发现更多的预后信息,我们训练了一个深度学习系统,直接从苏木精和伊红(H&E)染色的微阵列芯片组织中预测生化复发。我们利用对685例患者的巢式病例对照研究,通过卷积神经网络开发了一种形态学生物标志物,并在204例患者的独立队列中进行了验证。我们使用基于概念的可解释性方法来解释所学习到的组织模式。

结果

该生物标志物与来自不同机构的两组(n = 182和n = 204)生化复发具有强相关性。基于概念的解释提供了病理学家可解释的组织模式。

结论

这些结果表明,该模型在组织中发现了超出形态学国际泌尿病理学会(ISUP)分级的预测能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ca2/9177591/d8c7b3f83a45/43856_2022_126_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ca2/9177591/c90a548a0e36/43856_2022_126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ca2/9177591/2bf788d977bd/43856_2022_126_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ca2/9177591/d8c7b3f83a45/43856_2022_126_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ca2/9177591/c90a548a0e36/43856_2022_126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ca2/9177591/2bf788d977bd/43856_2022_126_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ca2/9177591/d8c7b3f83a45/43856_2022_126_Fig3_HTML.jpg

相似文献

1
Predicting biochemical recurrence of prostate cancer with artificial intelligence.利用人工智能预测前列腺癌的生化复发
Commun Med (Lond). 2022 Jun 8;2:64. doi: 10.1038/s43856-022-00126-3. eCollection 2022.
2
A selective CutMix approach improves generalizability of deep learning-based grading and risk assessment of prostate cancer.一种选择性CutMix方法提高了基于深度学习的前列腺癌分级和风险评估的泛化能力。
J Pathol Inform. 2024 May 7;15:100381. doi: 10.1016/j.jpi.2024.100381. eCollection 2024 Dec.
3
Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.前列腺癌核分级与根治性前列腺切除术后前列腺特异性抗原复发之间无相关性。
J Urol. 2001 Dec;166(6):2193-7.
4
Should we replace the Gleason score with the amount of high-grade prostate cancer?我们是否应该用高级别前列腺癌的数量来取代 Gleason 评分?
Eur Urol. 2007 Apr;51(4):931-9. doi: 10.1016/j.eururo.2006.07.051. Epub 2006 Aug 15.
5
Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.使用基于前列腺特异性抗原密度和活检Gleason评分的新型风险分组系统改善根治性前列腺切除术后生化复发的风险分层。
J Urol. 2002 Jul;168(1):110-5.
6
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
7
Comparison of Artificial Intelligence Techniques to Evaluate Performance of a Classifier for Automatic Grading of Prostate Cancer From Digitized Histopathologic Images.比较人工智能技术评估分类器在从数字化组织病理学图像自动分级前列腺癌方面的性能。
JAMA Netw Open. 2019 Mar 1;2(3):e190442. doi: 10.1001/jamanetworkopen.2019.0442.
8
Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score.前列腺穿刺活检组织中癌组织的百分比,相较于前列腺特异性抗原或 Gleason 评分,对根治性前列腺切除术后生化复发或不良病理结果更具预测性。
J Urol. 2002 Feb;167(2 Pt 1):516-20. doi: 10.1016/S0022-5347(01)69076-1.
9
Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups.新的前列腺癌国际泌尿病理学会分级组的预后价值
Front Med (Lausanne). 2017 Sep 29;4:157. doi: 10.3389/fmed.2017.00157. eCollection 2017.
10
Integrating tertiary Gleason pattern 5 into the ISUP grading system improves prediction of biochemical recurrence in radical prostatectomy patients.将三级 Gleason 模式 5 纳入 ISUP 分级系统可提高前列腺切除术患者生化复发的预测能力。
Mod Pathol. 2019 Jan;32(1):122-127. doi: 10.1038/s41379-018-0121-8. Epub 2018 Sep 4.

引用本文的文献

1
Artificial intelligence unravels interpretable malignancy grades of prostate cancer on histology images.人工智能在组织学图像上解析可解释的前列腺癌恶性等级。
Npj Imaging. 2024 Mar 6;2(1):6. doi: 10.1038/s44303-023-00005-z.
2
Artificial Intelligence-Based Digital Histologic Classifier for Prostate Cancer Risk Stratification: Independent Blinded Validation in Patients Treated With Radical Prostatectomy.基于人工智能的前列腺癌风险分层数字组织学分类器:接受根治性前列腺切除术患者的独立盲法验证
JCO Clin Cancer Inform. 2025 Jun;9:e2400292. doi: 10.1200/CCI-24-00292. Epub 2025 Jun 18.
3
The Role of Artificial Intelligence in the Evaluation of Prostate Pathology.

本文引用的文献

1
Stop Explaining Black Box Machine Learning Models for High Stakes Decisions and Use Interpretable Models Instead.停止为高风险决策解释黑箱机器学习模型,转而使用可解释模型。
Nat Mach Intell. 2019 May;1(5):206-215. doi: 10.1038/s42256-019-0048-x. Epub 2019 May 13.
2
ISUP Consensus Definition of Cribriform Pattern Prostate Cancer.ISUP 共识定义的筛状前列腺癌模式。
Am J Surg Pathol. 2021 Aug 1;45(8):1118-1126. doi: 10.1097/PAS.0000000000001728.
3
Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study.
人工智能在前列腺病理学评估中的作用。
Pathol Int. 2025 May;75(5):213-220. doi: 10.1111/pin.70015. Epub 2025 Apr 14.
4
A concept-based interpretable model for the diagnosis of choroid neoplasias using multimodal data.一种基于概念的可解释模型,用于利用多模态数据诊断脉络膜肿瘤。
Nat Commun. 2025 Apr 13;16(1):3504. doi: 10.1038/s41467-025-58801-7.
5
MRI-based radiomics for prediction of biochemical recurrence in prostate cancer: a systematic review and meta-analysis.基于MRI的影像组学预测前列腺癌生化复发:一项系统综述和荟萃分析
Abdom Radiol (NY). 2025 Mar 27. doi: 10.1007/s00261-025-04892-1.
6
Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies.通过将战略搭便车机制与技术相结合来理解癌症休眠。
Mol Cancer. 2025 Feb 14;24(1):47. doi: 10.1186/s12943-025-02250-9.
7
Artificial intelligence in digital pathology - time for a reality check.数字病理学中的人工智能——是时候进行现实核查了。
Nat Rev Clin Oncol. 2025 Apr;22(4):283-291. doi: 10.1038/s41571-025-00991-6. Epub 2025 Feb 11.
8
Development of a deep learning system for predicting biochemical recurrence in prostate cancer.用于预测前列腺癌生化复发的深度学习系统的开发。
BMC Cancer. 2025 Feb 10;25(1):232. doi: 10.1186/s12885-025-13628-9.
9
Prediction of biochemical prostate cancer recurrence from any Gleason score using robust tissue structure and clinically available information.利用稳健的组织结构和临床可用信息预测任何Gleason评分的前列腺癌生化复发情况。
Discov Oncol. 2025 Feb 7;16(1):128. doi: 10.1007/s12672-025-01896-7.
10
Harnessing machine learning to predict prostate cancer survival: a review.利用机器学习预测前列腺癌生存率:综述
Front Oncol. 2025 Jan 10;14:1502629. doi: 10.3389/fonc.2024.1502629. eCollection 2024.
计算机从苏木精和伊红染色切片中提取的腺体特征预测前列腺癌复发的能力与基因组伴随诊断测试相当:一项大型多中心研究。
NPJ Precis Oncol. 2021 May 3;5(1):35. doi: 10.1038/s41698-021-00174-3.
4
Interpretable survival prediction for colorectal cancer using deep learning.使用深度学习对结直肠癌进行可解释的生存预测。
NPJ Digit Med. 2021 Apr 19;4(1):71. doi: 10.1038/s41746-021-00427-2.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-EANM-ESTRO-ESUR-SIOG 前列腺癌指南-2020 版更新。第 1 部分:筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7.
7
Artificial intelligence to detect MYC translocation in slides of diffuse large B-cell lymphoma.人工智能检测弥漫性大 B 细胞淋巴瘤切片中的 MYC 易位。
Virchows Arch. 2021 Sep;479(3):617-621. doi: 10.1007/s00428-020-02931-4. Epub 2020 Sep 26.
8
Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome.前列腺癌中筛状结构和 4 级 Gleason 模式比例的观察者间变异性:与临床结果的关系。
Virchows Arch. 2021 Feb;478(2):249-256. doi: 10.1007/s00428-020-02902-9. Epub 2020 Aug 20.
9
Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients.在前列腺癌 Gleason 评分 8 分的患者中,根治性前列腺切除术中的筛状结构可预测肿瘤学结局。
Mod Pathol. 2021 Jan;34(1):184-193. doi: 10.1038/s41379-020-0625-x. Epub 2020 Jul 20.
10
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.2019 年国际泌尿病理学会(ISUP)前列腺癌分级共识会议。
Am J Surg Pathol. 2020 Aug;44(8):e87-e99. doi: 10.1097/PAS.0000000000001497.